0QN1 fundamentals
SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS) earnings per share and revenue
Company revenue for the same period amounts to 25.00 M CHF despite the estimated figure of 25.00 M CHF. Also watch annual changes over time to get a bigger picture of 0QN1 earnings per share and revenue dynamics.
Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise